Jeffrey J. Brown - 08 Nov 2021 Form 4 Insider Report for MEDIFAST INC (MED)

Role
Director
Signature
/s/ Jason L. Groves, attorney-in-fact
Issuer symbol
MED
Transactions as of
08 Nov 2021
Net transactions value
+$973,911
Form type
4
Filing time
10 Nov 2021, 20:17:44 UTC
Previous filing
20 Oct 2021
Next filing
04 Jan 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MED Common Stock Purchase $43,676 +200 +0.65% $218.49 30,957 08 Nov 2021 By Brown Equity Partners, LLC F1, F11
transaction MED Common Stock Purchase $35,994 +160 +0.52% $224.96 31,117 08 Nov 2021 By Brown Equity Partners, LLC F2, F11
transaction MED Common Stock Purchase $45,336 +200 +0.64% $226.68 31,317 08 Nov 2021 By Brown Equity Partners, LLC F3, F11
transaction MED Common Stock Purchase $45,556 +200 +0.64% $227.78 31,517 08 Nov 2021 By Brown Equity Partners, LLC F4, F11
transaction MED Common Stock Purchase $66,674 +290 +0.92% $229.91 31,807 08 Nov 2021 By Brown Equity Partners, LLC F5, F11
transaction MED Common Stock Purchase $34,748 +150 +0.47% $231.65 31,957 08 Nov 2021 By Brown Equity Partners, LLC F6, F11
transaction MED Common Stock Purchase $187,668 +807 +2.5% $232.55 32,764 08 Nov 2021 By Brown Equity Partners, LLC F7, F11
transaction MED Common Stock Purchase $138,572 +593 +1.8% $233.68 33,357 08 Nov 2021 By Brown Equity Partners, LLC F8, F11
transaction MED Common Stock Purchase $234,520 +1,000 +3% $234.52 34,357 08 Nov 2021 By Brown Equity Partners, LLC F9, F11
transaction MED Common Stock Purchase $141,168 +600 +1.7% $235.28 34,957 08 Nov 2021 By Brown Equity Partners, LLC F10, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were acquired by Brown Equity Partners, LLC, for which the reporting person is the managing member, pursuant to a broker-sponsored Dividend Reinvestment Plan.
F2 This transaction was executed in multiple trades at prices ranging from $224.67 USD to $225.45 USD; the price reported above reflects the weighted average sale price.
F3 This transaction was executed in multiple trades at prices ranging from $226.51 USD to $226.85 USD; the price reported above reflects the weighted average sale price.
F4 This transaction was executed in multiple trades at prices ranging from $227.61 USD to $227.95 USD; the price reported above reflects the weighted average sale price.
F5 This transaction was executed in multiple trades at prices ranging from $229.75 USD to $230.13 USD; the price reported above reflects the weighted average sale price.
F6 This transaction was executed in multiple trades at prices ranging from $231.57 USD to $231.82 USD; the price reported above reflects the weighted average sale price.
F7 This transaction was executed in multiple trades at prices ranging from $232.00 USD to $232.99 USD; the price reported above reflects the weighted average sale price.
F8 This transaction was executed in multiple trades at prices ranging from $233.12 USD to $233.96 USD; the price reported above reflects the weighted average sale price.
F9 This transaction was executed in multiple trades at prices ranging from $234.11 USD to $234.99 USD; the price reported above reflects the weighted average sale price.
F10 This transaction was executed in multiple trades at prices ranging from $235.00 USD to $235.71 USD; the price reported above reflects the weighted average sale price.
F11 These shares are directly owned by Brown Equity Partners, LLC, for which the reporting person is the managing member.